Inducible promoter
    11.
    发明申请
    Inducible promoter 失效
    诱导启动子

    公开(公告)号:US20040248303A1

    公开(公告)日:2004-12-09

    申请号:US10760752

    申请日:2004-01-20

    摘要: The Arabidopsis NI16 gene was isolated in a yeast 2-hybrid screen via its interaction with the NIM1 protein and encodes a protein involved in the regulation of SAR gene expression in plants. NI16 is strongly induced in NIM1-overexpressing plants treated with benzo(1,2,3)thiadiazole-7-carbothioic acid S-methyl ester (BTH). The nucleic acid sequence of the Arabidopsis NI16 promoter is disclosed herein.

    摘要翻译: 通过与NIM1蛋白的相互作用,在酵母2-杂交筛选中分离拟南芥NI16基因,并编码参与植物中SAR基因表达调控的蛋白质。 NI16在用苯并(1,2,3)噻二唑-7-硫代硫酸S-甲酯(BTH)处理的NIM1过表达植物中强烈诱导。 本文公开了拟南芥NI16启动子的核酸序列。

    Pyrophosphatase stress-related proteins and methods of use in plants
    14.
    发明申请
    Pyrophosphatase stress-related proteins and methods of use in plants 失效
    焦磷酸酶应激相关蛋白和植物中使用的方法

    公开(公告)号:US20040055032A1

    公开(公告)日:2004-03-18

    申请号:US10169045

    申请日:2002-11-18

    摘要: A transgenic plant transformed by a pyrophosphatase stress-related protein (PPSRP) coding nucleic acid, wherein expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress as compared to a wild type variety of the plant. Also provided are agricultural products, including seeds, produced by the transgenic plants. Also provided are isolated PPSRP, and isolated nucleic acid coding PPSRP, and vectors and host cells containing the latter. Further provided are methods of producing transgenic plants expressing PPSRP, methods of identifying novel PPSRP, and methods of modifying the expression of PPSRP in plants.

    摘要翻译: 通过焦磷酸酶应激相关蛋白(PPSRP)编码核酸转化的转基因植物,其中核酸序列在植物中的表达与植物的野生型品种相比,导致对环境胁迫的耐受性增加。 还提供了由转基因植物生产的农产品,包括种子。 还提供了分离的PPSRP和分离的编码PPSRP的核酸,以及含有后者的载体和宿主细胞。 还提供了生产表达PPSRP的转基因植物的方法,鉴定新型PPSRP的方法以及修饰植物中PPSRP表达的方法。

    Inactivation resistant factor VIII related applications
    19.
    发明申请
    Inactivation resistant factor VIII related applications 失效
    灭活抗因子VIII相关应用

    公开(公告)号:US20020132306A1

    公开(公告)日:2002-09-19

    申请号:US09819098

    申请日:2001-04-11

    CPC分类号: C07K14/755 A61K38/00

    摘要: The present invention provides novel purified and isolated nucleic acid sequences encoding procoagulant-active FVIII proteins. The nucleic acid sequences of the present invention encode amino acid sequences corresponding to known human FVIII sequences, wherein residue Phe3O9 is mutated. The nucleic acid sequences of the present invention also encode amino acid sequences corresponding to known human FVIII sequences, wherein the APC cleavage sites, Arg336 and Ile562, are mutated. The nucleic acid sequences of the present invention further encode amino acid sequences corresponding to known human FVIII sequences, wherein the B-domain is deleted, the von Willebrand factor binding site is deleted, a thrombin cleavage site is mutated and an amino acid sequence spacer is inserted between the A2- and A3-domains. Methods of producing the FVIII proteins of the invention, nucleotide sequences encoding such proteins, pharmaceutical compositions containing the nucleotide sequences or proteins, as well as methods of treating patients suffering from hemophilia, are also provided.

    摘要翻译: 本发明提供了编码促凝血活性FVIII蛋白的新型纯化和分离的核酸序列。 本发明的核酸序列编码对应于已知人FVIII序列的氨基酸序列,其中残基Phe3O9被突变。 本发明的核酸序列还编码对应于已知人FVIII序列的氨基酸序列,其中APC切割位点Arg336和Ile562突变。 本发明的核酸序列进一步编码对应于已知人FVIII序列的氨基酸序列,其中缺失B结构域,缺失血管性血友病因子结合位点,突变凝血酶切割位点,氨基酸序列间隔物为 插入在A2-和A3-域之间。 还提供了产生本发明的FVIII蛋白的方法,编码这种蛋白质的核苷酸序列,含有核苷酸序列或蛋白质的药物组合物,以及治疗患有血友病的患者的方法。